Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine cataplasm for diabetic peripheral neuropathic pain
CTR20212038Phase 3Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in diabetic polyneuropathy (DPN), sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Aug 2021; status: completed.
02
Drugs
lidocaine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20212038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212038.